GELS (Gelteq Limited Ordinary Shares) Stock Analysis - SEC Filings

Gelteq Limited Ordinary Shares (GELS) is a publicly traded Healthcare sector company. As of May 21, 2026, GELS trades at $0.46 with a market cap of $4.34M and a P/E ratio of 0.00. GELS moved +27.74% today. Year to date, GELS is -43.11%; over the trailing twelve months it is -73.39%. Its 52-week range spans $0.39 to $5.50. Rallies surfaces GELS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find GELS SEC filings?

Rallies organizes GELS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

GELS Key Metrics

Key financial metrics for GELS
MetricValue
Price$0.46
Market Cap$4.34M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.50
52-Week Low$0.39
Volume1.95K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest GELS News

GELS Analyst Consensus

GELS analyst coverage data. Average price target: $0.00.

Common questions about GELS

Where can I find GELS SEC filings?
Rallies organizes GELS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show GELS 10-K and 10-Q filings?
Rallies organizes GELS SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is GELS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GELS. It does not provide personalized investment advice.
GELS

GELS